{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:50:07Z","timestamp":1762159807347},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1006\/gyno.2001.6549","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T15:02:41Z","timestamp":1033916561000},"page":"431-436","source":"Crossref","is-referenced-by-count":11,"title":["Reduced Expression of Early Growth Response-1 Gene in Leiomyoma as Identified by mRNA Differential Display"],"prefix":"10.1006","volume":"84","author":[{"given":"Corina A.","family":"Pambuccian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela M.","family":"Oprea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Lakatua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2001.6549_RF1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/00003081-199712000-00022","article-title":"Hysterectomy: improving the patients' decision-making process","volume":"40","author":"Gambone","year":"1997","journal-title":"Clin Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6549_RF2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1126\/science.150.3692.67","article-title":"Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas","volume":"150","author":"Linder","year":"1965","journal-title":"Science"},{"key":"10.1006\/gyno.2001.6549_RF3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.2870110102","article-title":"Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata","volume":"11","author":"Mashal","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1006\/gyno.2001.6549_RF4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/molehr\/4.1.83","article-title":"Cytogenetic abnormalities in uterine myomas are associated with myoma size","volume":"4","author":"Rein","year":"1998","journal-title":"Mol Hum Reprod"},{"key":"10.1006\/gyno.2001.6549_RF5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0015-0282(97)00472-X","article-title":"Clinical significance of cytogenetic abnormalities in uterine myoma","volume":"69","author":"Brosens","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1006\/gyno.2001.6549_RF6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0002-9440(10)65645-3","article-title":"Warner\u2013Lambert\/Parke\u2013Davis Award lecture. Many tumors and many genes: genetics of uterine leiomyomata","volume":"153","author":"Morton","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1006\/gyno.2001.6549_RF7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/1071-5576(95)00021-6","article-title":"Abnormal gene expression in uterine leiomyomas","volume":"2","author":"Andersen","year":"1995","journal-title":"J Soc Gynecol Invest"},{"key":"10.1006\/gyno.2001.6549_RF8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0002-9378(93)90293-R","article-title":"Expression of connexin-43 in human myometrium and leiomyoma","volume":"169","author":"Andersen","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6549_RF9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0015-0282(16)54681-0","article-title":"Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata","volume":"56","author":"Yeh","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1006\/gyno.2001.6549_RF10","first-page":"900","article-title":"Relative overexpression of collagen type I and collagen type III mesenger RNAs by uterine leiomyomas during the proliferative phase of the menstrual cycle","volume":"79","author":"Stewart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1006\/gyno.2001.6549_RF11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-1018892","article-title":"Uterine myomas and cancer","volume":"10","author":"Hamlin","year":"1992","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1006\/gyno.2001.6549_RF12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2007-1018887","article-title":"Uterine leiomyomas: the somatic mutation theory","volume":"10","author":"Barbieri","year":"1992","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1006\/gyno.2001.6549_RF13","series-title":"Detection and differential display of expressed genes by DDRT-PCR. PCR methods and applications","author":"Bauer","year":"1994"},{"key":"10.1006\/gyno.2001.6549_RF14","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"1989"},{"key":"10.1006\/gyno.2001.6549_RF15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L","article-title":"Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation","volume":"72","author":"Huang","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1006\/gyno.2001.6549_RF16","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1073\/pnas.90.12.5484","article-title":"Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases","volume":"90","author":"Le Beau","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/gyno.2001.6549_RF17","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1074\/jbc.274.7.4400","article-title":"The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta-1, fibronectin, and plasminogen activator inhibitor-1","volume":"274","author":"Liu","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1006\/gyno.2001.6549_RF18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1289\/ehp.00108s5849","article-title":"Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors","volume":"108","author":"Nowak","year":"2000","journal-title":"Environ Health Perspect"},{"key":"10.1006\/gyno.2001.6549_RF19","doi-asserted-by":"crossref","first-page":"11831","DOI":"10.1073\/pnas.93.21.11831","article-title":"Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta-1","volume":"93","author":"Liu","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/gyno.2001.6549_RF20","doi-asserted-by":"crossref","first-page":"38524","DOI":"10.1074\/jbc.M005220200","article-title":"EGR1 target genes in prostate carcinoma cells identified by microarray analysis","volume":"275","author":"Svaren","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1006\/gyno.2001.6549_RF21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/PL00008488","article-title":"Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array","volume":"126","author":"Xie","year":"2000","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1006\/gyno.2001.6549_RF22","first-page":"17","article-title":"Identification of a specific pattern of \u201cimmediate-early\u201d gene activation induced by estrogen during mitogenic stimulation of rat uterine cells","volume":"3","author":"Cicatiello","year":"1993","journal-title":"Receptor"},{"key":"10.1006\/gyno.2001.6549_RF23","doi-asserted-by":"crossref","first-page":"25266","DOI":"10.1074\/jbc.270.42.25266","article-title":"Promoter analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin","volume":"270","author":"Lai","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1006\/gyno.2001.6549_RF24","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/sj.onc.1203474","article-title":"Similar but distinct effects of the tristetraprolin\/TIS11 immediate-early proteins on cell survival","volume":"19","author":"Johnson","year":"2000","journal-title":"Oncogene"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801965497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801965497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T11:21:40Z","timestamp":1554981700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825801965497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0090825801965497"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2001.6549","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}